Literature DB >> 10708606

The suppression of small GTPase rho signal transduction pathway inhibits angiogenesis in vitro and in vivo.

S Uchida1, G Watanabe, Y Shimada, M Maeda, A Kawabe, A Mori, S Arii, M Uehata, T Kishimoto, T Oikawa, M Imamura.   

Abstract

Angiogenesis consists of multistep pathways such as the degradation of the matrix, proliferation of the endothelial cells, motility of the endothelial cells, formation of the cord structure and network formation of microvessels. The small GTPase Rho participates in cell motility through actin fiber polymerization. The role of the small GTPase Rho signal transduction pathway in regulating angiogenesis, however, is still unknown. In this study, we investigated the role of the small GTPase Rho signal transduction pathway in angiogenesis in vitro and in vivo using the exoenzyme, Clostridium botulinum C3 transferase, which specifically suppresses Rho and a compound, Y-27632, which suppresses p160ROCK (Rho-associated coiled-coil containing protein kinase). In this paper, we showed that the small GTPase Rho-p160ROCK signal transduction pathway played an important role in angiogenesis both in vitro and in vivo. These results suggest that inhibition of the small GTPase Rho signal transduction pathway by the p160ROCK inhibitor could be a possible new strategy for angiogenic diseases. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708606     DOI: 10.1006/bbrc.2000.2315

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Rho activity critically and selectively regulates endothelial cell organization during angiogenesis.

Authors:  Mien V Hoang; Mary C Whelan; Donald R Senger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis.

Authors:  Zhi-Jian Su; Christopher N Hahn; Gregory J Goodall; Niamh M Reck; Annabell F Leske; Ann Davy; Gabriel Kremmidiotis; Mathew A Vadas; Jennifer R Gamble
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

3.  PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells.

Authors:  Heather N Woodward; Adil Anwar; Suzette Riddle; Laimute Taraseviciene-Stewart; Miguel Fragoso; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

4.  A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease.

Authors:  Lisa McKerracher; Robert Shenkar; Matthew Abbinanti; Ying Cao; Amy Peiper; James K Liao; Rhonda Lightle; Thomas Moore; Nicholas Hobson; Carol Gallione; Joerg Ruschel; Janne Koskimäki; Romuald Girard; Kenneth Rosen; Douglas A Marchuk; Issam A Awad
Journal:  Transl Stroke Res       Date:  2019-08-24       Impact factor: 6.829

5.  Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2).

Authors:  Roberta Pireddu; Kara D Forinash; Nan N Sun; Mathew P Martin; Shen-Shu Sung; Brian Alexander; Jin-Yi Zhu; Wayne C Guida; Ernst Schönbrunn; Saïd M Sebti; Nicholas J Lawrence
Journal:  Medchemcomm       Date:  2012-01-27       Impact factor: 3.597

6.  The interplay of cyclic stretch and vascular endothelial growth factor in regulating the initial steps for angiogenesis.

Authors:  Justin R Wilkins; Daniel B Pike; Christopher C Gibson; Li Li; Yan-Ting Shiu
Journal:  Biotechnol Prog       Date:  2014-11-13

Review 7.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

8.  A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor.

Authors:  Jasmina Profirovic; Elena Strekalova; Norifumi Urao; Aleksandar Krbanjevic; Alexandra V Andreeva; Sudhahar Varadarajan; Tohru Fukai; René Hen; Masuko Ushio-Fukai; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2012-08-18       Impact factor: 9.596

9.  Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing.

Authors:  P V Jensen; L-I Larsson
Journal:  Histochem Cell Biol       Date:  2004-04-22       Impact factor: 4.304

10.  MIP-2 causes differential activation of RhoA in mouse aortic versus pulmonary artery endothelial cells.

Authors:  Aigul Moldobaeva; Amy Baek; Elizabeth M Wagner
Journal:  Microvasc Res       Date:  2007-07-06       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.